文献速递质量管理与危急值分子诊断

意大利临床实验室人工智能与大数据应用调查

A survey on Artificial Intelligence and Big Data utilisation in Italian clinical laboratories.
PubMed 文献 · Clin Chem Lab Med · 2022-09-06

SIBioC大数据与人工智能工作组向1351名参与者发放问卷,评估实验室数字化、IT基础设施、数据可及性及BAI项目现状。227名受访者(17%)来自全意484家实验室中的47%,主要发现硬件软件不足、仅25%每日使用云、65%无法获取实验室外健康数据、极少数已开展BAI项目,但多数认为BAI对专业判断至关重要。

要点

  • 仅25%受访者每日使用云,65%无法获取实验室外健康数据。
  • 不足半数可查看患者完整健康记录,数据整合多不完整。
  • 极少数已开展BAI项目,多依赖IT合作,但多数认可其重要性。

核心结论

  • 受访者对BAI应用有一定专业知识和兴趣,但IT基础设施、数据仓库、分析软件、数据可及性和培训均需全面改进。

研究设计与样本

  • SIBioC BAI工作组发放问卷,聚焦数字化、IT基础设施、数据可及性和BAI项目,发送给1351名SIBioC参与者,用SurveyMonkey和Google Sheets评估。

主要发现

  • 227名受访者(17%)来自全意484家实验室中的47%,主要为生物学家、实验室医师和管理者,多来自公立医院实验室。
  • 调查揭示硬件、软件和企业Wi-Fi缺乏,个人电脑不足。
  • 仅25%每日使用云,65%(包括实验室主任)无法从实验室外来源获取健康数据。
  • 有访问权限者中仅50%可查看临床患者健康记录,其余仅能访问实验室信息。
  • 实验室数据与其他健康数据整合多不完整,限制BAI分析;许多人不了解集成平台;超90%报告从LIS提取数据,自主程度不一;极少数已开展BAI项目,常依赖IT合作。

临床怎么用

  • 实验室需优先加强IT基础设施、数据仓库和BAI分析软件建设。
  • 提升数据可及性,整合实验室与外部健康数据以支持BAI分析。
  • 开展BAI培训,提高实验室人员对集成平台和数据分析的认知。

局限性

  • 问卷回复率仅17%(227/1351),可能存在无应答偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) Big Data and Artificial Intelligence (BAI) Working Group promoted a survey to frame the knowledge, skills and technological predisposition in clinical laboratories. METHODS: A questionnaire, focussing on digitization, information technology (IT) infrastructures, data accessibility, and BAI projects underway was sent to 1,351 SIBioC participants. The responses were evaluated using SurveyMonkey software and Google Sheets. RESULTS: The 227 respondents (17%) from all over Italy (47% of 484 labs), mainly biologists, laboratory physicians and managers, mostly from laboratories of public hospitals, revealed lack of hardware, software and corporate Wi-Fi, and dearth of PCs. Only 25% work daily on clouds, while 65%-including Laboratory Directors-cannot acquire health data from sources other than laboratories. Only 50% of those with access can review a clinical patient's health record, while the other access only to laboratory information. The integration of laboratory data with other health data is mostly incomplete, which limits BAI-type analysis. Many are unaware of integration platforms. Over 90% report pulling data from the Laboratory Information System, with varying degrees of autonomy. Very few have already undertaken BAI projects, frequently relying on IT partnerships. The majority consider BAI as crucial in helping professional judgements, indicating a growing interest. CONCLUSIONS: The questionnaire received relevant feedback from SIBioC participants. It highlighted the level of expertise and interest in BAI applications. None of the obstacles stands out more than the others, emphasising the need to all-around work: IT infrastructures, data warehouses, BAI analysis software acquisition, data accessibility and training.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Bellini C, Padoan A, Carobene A, et al. A survey on Artificial Intelligence and Big Data utilisation in Italian clinical laboratories. Clin Chem Lab Med. 2022. PMID: 36067004. doi:10.1515/cclm-2022-0680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。